Remodulin

The oral version of treprostinal, which is also known as Remodulin and is already approved in injectable and inhaleable forms, increased the distance that patients could walk in six minutes by 10 meters, but this difference was below what doctors and analysts expected and was not statistically significant, meaning it could be due to chance.

unknown title 2011

Some analysts worry that the inhaled drug, Tyvaso, will cannibalize Remodulin sales, but Rothblatt says there is a market, since Remodulin currently must be injected.

From Satellites To Pharmaceuticals 2010

Remodulin was delayed for two years, but the drug was finally approved in 2002 after a second study and priced at $90,000 per year.

From Satellites To Pharmaceuticals 2010

Some analysts worry that the inhaled drug, Tyvaso, will cannibalize Remodulin sales, but Rothblatt says there is a market, since Remodulin currently must be injected.

From Satellites To Pharmaceuticals 2010

Jonathan Aschoff, the biotech analyst at investment bank Brean Murray Carret, expects strong sales and late-stage results of an oral Remodulin formulation to goose the stock.

From Satellites To Pharmaceuticals 2010

United Therapeutics shares are up 800% since the company went public in 1999 and have doubled in the past year because of hopes for a new inhaled version of Remodulin and a deal with Eli Lilly

From Satellites To Pharmaceuticals 2010

Revenue jumped 62 percent, to $128.9 million, from $79.7 million, as sales of Remodulin grew and the FDA approved Tyvaso and Adcirca in 2009.

Google wins Rosetta Stone ruling; HGS posts loss; United Therapeutics has boost 2010

Remodulin was delayed for two years, but the drug was finally approved in 2002 after a second study and priced at $90,000 per year.

From Satellites To Pharmaceuticals 2010

Things get tougher when the Remodulin patent expires in 2014.

From Satellites To Pharmaceuticals 2010

Things get tougher when the Remodulin patent expires in 2014.

From Satellites To Pharmaceuticals 2010